Physician profile
Brandon Drafts
NPI 1336309095
$11,056.54
in general payments reported to CMS, 2019-2025
40 companies · $1,251 in 2025
The $1,251 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,978 · 2020: $566 · 2021: $864 · 2022: $1,828 · 2023: $2,013 · 2024: $2,556 · 2025: $1,251.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,804 · Travel and Lodging: $1,016.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,803.53 |
| Travel and Lodging | $1,016.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,408.44 | 2019-2025 | Mitraclip, Navitor, Thoratec Heartmate 3 Lvas Implant Kit |
| Inari Medical, INC. | $1,375.58 | 2022-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Medtronic, INC. | $1,157.05 | 2021-2025 | Micra, Onyx Frontier, Linq II |
| Boston Scientific Corporation | $943.85 | 2019-2024 | Avvigo Guidance System, Watchman Access System |
| Novartis Pharmaceuticals Corporation | $818.07 | 2019-2025 | |
| Edwards Lifesciences Corporation | $472.89 | 2019-2025 | Sapien 3 Ultra Resilia |
| E.R. Squibb & Sons, L.L.C. | $296.66 | 2019-2025 | Camzyos, Eliquis |
| Abiomed | $266.86 | 2022-2025 | Impella |
| Stryker Corporation | $266.06 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $252.59 | 2019-2024 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $209.26 | 2019-2025 | Farxiga |
| Pfizer INC. | $177.46 | 2019-2023 | |
| Amgen INC. | $139.99 | 2019-2024 | Repatha |
| Shockwave Medical, INC | $120.00 | 2021-2025 | |
| Sanofi-Aventis U.S. LLC | $113.24 | 2019 |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brandon Drafts listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.